Healthcare provider profile · identity verified

Lynnett M Wilderman, PA-C

Physician Assistant · PLYMOUTH, WI · NPI 1861509721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	490	123
Metoprolol Succinate	Metoprolol Succinate	246	69
Levothyroxine Sodium	Levothyroxine Sodium	233	56
Losartan Potassium	Losartan Potassium	200	53
Amlodipine Besylate	Amlodipine Besylate	177	48
Alendronate Sodium	Alendronate Sodium	163	41
Pantoprazole Sodium	Pantoprazole Sodium	133	40
Sertraline Hcl	Sertraline Hcl	131	26
Rosuvastatin Calcium	Rosuvastatin Calcium	130	36
Omeprazole	Omeprazole	127	37
Metformin Hcl Er	Metformin Hcl	125	34
Lisinopril	Lisinopril	122	31
Simvastatin	Simvastatin	119	32
Furosemide	Furosemide	108	33
Escitalopram Oxalate	Escitalopram Oxalate	98	23
Hydrochlorothiazide	Hydrochlorothiazide	93	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	22
Trazodone Hcl	Trazodone Hcl	73	19
Fluticasone Propionate	Fluticasone Propionate	69	28
Tamsulosin Hcl	Tamsulosin Hcl	64	15
Gabapentin	Gabapentin	60	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	15
Fluoxetine Hcl	Fluoxetine Hcl	55	15
Allopurinol	Allopurinol	53	14
Bupropion Xl	Bupropion Hcl	51	12
Tramadol Hcl	Tramadol Hcl	51	11
Meloxicam	Meloxicam	49	18
Tizanidine Hcl	Tizanidine Hcl	49	17
Metformin Hcl	Metformin Hcl	47	14
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	21
Metoprolol Tartrate	Metoprolol Tartrate	44	14
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Eliquis	Apixaban	40	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Glipizide Er	Glipizide	37	14
Mounjaro	Tirzepatide	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Alprazolam	Alprazolam	32	19
Atenolol	Atenolol	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	28
Prednisone	Prednisone	31	20
Potassium Chloride	Potassium Chloride	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Famotidine	Famotidine	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Estradiol	Estradiol	24	12
Finasteride	Finasteride	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Valsartan	Valsartan	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	14
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	15
Lovastatin	Lovastatin	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Diazepam	Diazepam	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error